Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Pituitary|May 27, 2014
Update on prognostic factors in acromegaly: Is a risk score possible?E Fernandez-Rodriguez, F F Casanueva, I BernabeuMedicina Clinica|November 11, 1989
[Thyrotropin-producing adenoma of the hypophysis]R Araujo, J Estrada, S Díez, et al.Pituitary|April 9, 2014
Influence of the exon 3 deletion of GH receptor and IGF-I level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiencyP Andujar-Plata, E Fernandez-Rodriguez, C Quinteiro, et al.Endocrinologia Japonica|October 1, 1991
Anterior pituitary function in Cushing's syndrome: study of 36 patientsC Cuerda, J Estrada, M Marazuela, et al.Endocrine|March 5, 2021
Pituitary surgery in elderly patients: a safe and effective procedureR Villar-Taibo, C Díaz-Ortega, M Sifontes-Dubon, et al.Clinical Endocrinology|August 1, 2012
Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patientsE Fernandez-Rodriguez, M Lopez-Raton, P Andujar, et al.Pituitary|March 8, 2012
Pegvisomant and cabergoline combination therapy in acromegalyI Bernabeu, C Alvarez-Escolá, A E Paniagua, et al.Pituitary|November 11, 2015
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDYI Bernabeu, A Pico, E Venegas, et al.The Journal of Clinical Endocrinology and Metabolism|November 12, 2010
Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular studyM Marazuela, A E Paniagua, M D Gahete, et al.Oncogene|July 26, 2016
Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancerA R Garcia-Rendueles, J S Rodrigues, M E R Garcia-Rendueles, et al.Pageof 1